Identification of a Small Secretoneurin Derivative That Inhibits CaMKIIδ Activity
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Ilde Rugolo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, Secretogranin II, Neuropeptides. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nasjonalforeningen for Folkehelsen, Stiftelsen Kristian Gerhard Jebsen, Akershus Universitetssykehus.
Abstract (Originalsprache)
Ventricular arrhythmias, a major cause of sudden cardiac death, are driven by Ca 2+ imbalance in cardiac myocytes, often linked to the overactivation of CaMKIIδ (Ca 2+ /calmodulin‐dependent protein kinase II delta). As such, inhibiting CaMKIIδ represents a promising therapeutic strategy. Based on our previous finding that native secretoneurin (SN) is a weak CaMKIIδ inhibitor, we aimed to develop a more potent derivative of SN to effectively counter aberrant Ca 2+ handling and arrhythmia risk. Various regions of SN were tested for CaMKII binding, identifying the core region as the sequence with the strongest binding capacity. This region was subsequently optimised with two phenylalanine substitutions, resulting in the SN derivative SN‐db‐short. Structural homology modeling and ELISA‐based assays revealed that SN‐db‐short bound both the substrate‐binding (S‐site) region of CaMKIIδ, in addition to the ATP‐binding region, with 8‐fold stronger binding compared to SN. Surface plasmon resonance experiments confirmed that SN‐db‐short exhibited a higher association rate and affinity for CaMKIIδ compared to SN. Consistent with only a partial calmodulin binding motif, SN‐db‐short showed no calmodulin binding, indicating selective CaMKIIδ inhibition. In functional studies, SN‐db‐short inhibited CaMKIIδ‐mediated phosphorylation of ryanodine receptor 2 and appeared more effective than SN in reducing the incidence of Ca 2+ sparks and Ca 2+ waves. SN‐db‐short also more markedly inhibited CaMKIIδ phosphorylation of phospholamban, slowed Ca 2+ reuptake, and reduced the magnitude of Ca 2+ transients during isoproterenol stimulation. SN‐db‐short effectively inhibits CaMKIIδ and significantly counters aberrant Ca 2+ handling in cardiomyocytes. Thus, this optimised peptide holds therapeutic potential for reducing the risk of ventricular arrhythmias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway.
- Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway.
- K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Microbiology, Oslo University Hospital, Oslo, Norway.
- Department of Medical Biochemistry, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Ilde Rugolo
Förderung
- Nasjonalforeningen for Folkehelsen
- Stiftelsen Kristian Gerhard Jebsen
- Akershus Universitetssykehus
- South-Eastern Norway Regional Health Authority
Zitieren
APA
Rugolo, I., Shen, X., Støle, T. P., Bergan-Dahl, A., Manfra, O., Lunde, M., Christensen, G., Dalhus, B., Louch, W. E., Ottesen, A. H., Røsjø, H., & Carlson, C. R. (2025). Identification of a Small Secretoneurin Derivative That Inhibits CaMKIIδ Activity. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70900
Vancouver
Rugolo I, Shen X, Støle TP, Bergan-Dahl A, Manfra O, Lunde M, et al. Identification of a Small Secretoneurin Derivative That Inhibits CaMKIIδ Activity. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70900
BibTeX
@article{Rugolo2025,
author = {Rugolo, Ilde and Shen, Xin and Støle, Thea Parsberg and Bergan-Dahl, Anna and Manfra, Ornella and Lunde, Marianne and Christensen, Geir and Dalhus, Bjørn and Louch, William E and Ottesen, Anett H and Røsjø, Helge and Carlson, Cathrine Rein},
title = {Identification of a Small Secretoneurin Derivative That Inhibits CaMKIIδ Activity},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70900}
}
EUVIMED